Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 14 Prostatic Neoplasms 3 Uterine Cervical Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pleural Effusion, Malignant 2 Ovarian Neoplasms 2 Leukemia, Myeloid, Acute 2 Infertility 2 Hodgkin Disease 2 Endometrial Neoplasms 2 Thyroid Nodule 1 Thromboembolism 1 Stomach Neoplasms 1 Soft Tissue Neoplasms 1 Small Cell Lung Carcinoma 1 Sexuality 1 Sexual Dysfunction, Physiological 1 Sarcoma 1 Risk Malignant Index 1 Renal Insufficiency, Chronic 1 Recurrence 1 Rectal Neoplasms 1 Popliteal Cyst 1 Polycystic Ovary Syndrome 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1

Interventions

Hepatectomy 10 Blood Specimen Collection 9 Sorafenib 7 Polymerase Chain Reaction 4 Biopsy 4 regorafenib 3 Mass Spectrometry 3 Liver Transplantation 3 Immunohistochemistry 3 Chemoembolization, Therapeutic 3 Walking Speed 2 Surveys and Questionnaires 2 Psychiatric Rehabilitation 2 Magnetic Resonance Imaging 2 Gene Expression Profiling 2 Bevacizumab 2 trastuzumab deruxtecan 1 taxane 1 spartalizumab 1 sintilimab 1 lenvatinib 1 gadolinium ethoxybenzyl DTPA 1 donafenib 1 carmofur 1 camrelizumab 1 cabozantinib 1 atezolizumab 1 apatinib 1 anlotinib 1 Yttrium-90 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Liver Neoplasms × High-Energy Shock Waves × Clear all

NCT02501980 2023-07-13

HCC

Zhongshan People's Hospital, Guangdong, China

20,000 enrolled

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡